top left cornertop right corner
Blackburn with Darwen Primary Care Trust - About Us
.

Medicines Management in the East Lancashire Health Economy

ntal H Wk

 

Mental Health Awareness Week 2013

The theme for this year's campaign, which runs from 13-19 May, will be physical activity and exercise, highlighting the impact they have on mental health and wellbeing.

 

Information on this website has been provided by the East Lancashire Medicines Management Board which oversees Medicines Management issues across the East Lancashire Health Economy (population 522,000), which consists of;

 

 

The Medicines Management Board (MMB)  consists of physicians and representatives of other key decision-makers in the use of medicines in primary and secondary care. The remit of this board is to review selected pharmaceutical products to assess their clinical value, safety and suitability for use in the East Lancashire Health Economy, and to guide all prescribers in primary and secondary care in using them appropriately.

 

Typical drugs that are considered include newly licensed drugs or those that have a new indication and drugs used to treat conditions with which primary care prescribers may be less familiar. Unlicensed drugs and individual requests are also considered. Requests for drugs to be reviewed may be made by any health care professional in the East Lancashire Health Economy.

The recommendations of the MMB and the evidence considered in the evaluations are summarised in the New Drug Reviews. When use with a shared care agreement is recommended for a particular drug an effective Shared Care Agreement is provided for local use. These documents are available on the website under " New Drug Reviews ” and “ Shared Care Protocols ” respectively.  

 

Any decisions on drug use are also included into the Joint Medicines Formulary, which acts as a

reference to medicines approved for use in East Lancashire.  The Joint Medicines Formulary is formatted in the same style of the BNF, and provides all prescribers with a defined list of medicines that are available to prescribe, as well as the traffic light recommendation for each and any other recommendations for their use.  The Joint Medicines Formulary is available on the website under the “ Medicines Formulary ” heading above. Within East Lancashire a Joint Wound Care Formulary has also been developed, which forms the basis for the prescribing of cost effective and evaluated wound care products, as well as giving guidance on selection of dressing, specialist products, and available sizes.  It is available on the website under the " Wound Care Formulary " heading above.

 

The MMB also provides supporting information on some general prescribing issues (e.g. product withdrawals) as well as ratifying prescribing and clinical guidelines, treatment protocols and integrated care pathways for use across East Lancashire, all of which can be found above under  "Guidelines ".

 

Latest decisions of the MMB are listed on the MMB website update email that is sent out each month.  Health care professionals in East Lancashire can also register to receive this and other news by clicking on the link at the top of the page.  Planned activities and other relevant news items can be found in our monthly newsletter  INTERFACE that is distributed to all healthcare professionals across East Lancashire and is also available online under the heading “ Newsletters & Minutes ” on the left hand navigation panel.

 

For Freedom of Information Requests, please contact:

foi@bwd.nhs.uk – NHS Blackburn with Darwen

foi@eastlancspct.nhs.uk – NHS East Lancashire

 

This website only uses essential, non-intrusive cookies, which are removed from your computer once you've left.

Click here to learn more about cookies.

 

 

Latest Updates by Section

INTERFACE - Latest Edition

NICE Bites - Latest Edition

 

MHRA Drug Safety Update -

Latest Edition

 

Drug Alerts and Withdrawals

 

7th May 2013

 

Class 4 Drug Alert - update to alert 30th April 2013


Drug Alerts and Withdrawals

 

30th April 2013

 

Class 4 Drug Alert - caution in use - Aurum Pharmaceuticals (trading as Martindale Pharma)


Newsletters and Minutes

 

30th April 2013

 

NICE BITES April 2013 - click here


 

Newsletters and Minutes

 

30th April 2013

 

Drug Safety Update - April 2013


Drug Alerts and Withdrawls

 

25th April 2013

 

Class 3 Drug Alert -Diazepam 2mg Tablets TEVA UK - recall of all stock


 

Other Clinical Guidelines

 

22nd April 2013

 

STOPP:START Toolkit. Supporting Medication Review 


 

Clinical Guidelnes

 

22nd April 2013

 

Guidelines for Good Prescribing in Primary Care


Drug Alerts and Withdrawls

 

22nd April 2013

 

MHRA warns of the dangers of taking unlicensed herbal medicines containing aconite


Condition Specific Guidelines

 

19th April 2013

 

Management of Constipation in Adults ELHE


Non Clinical Guidelines

 

19th April 2013

 

Infant Feeding Manual (LCFT)


Medicine Specific Guidelines

 

19th April 2013

 

Position Statement for Omacor Prescribing in Post MI Patients


Condition Specific Guidelines

 

19th April 2013

 

Guidelines for the Prevention and Management of Osteoporosis in Adults


Medicine Specific Guidelines

 

19th April 2013

 

Guidelines for Management of Patients taking Long term Bisphosphonate Therapy


 New Drug Reviews

 

19th April 2013

 

Policy Statement (NHSCB)Ritiximab for Systemic Lupus Erythematosus


Newsletters and Minutes

 

19th April 2013

 

Medicines Management Board Minutes March 2013


Requesting a Policy Decision for Medicines

 

19th April 2013

 

Priority Setting of New Medicines Over-arching Policy April 2013


Drug Alerts and Withdrawls

 

 12th April 2013

  

 Medical Device Alert - Lifescan One Touch Verio Pro and Verio IQ

 


Disease or Condition Guidelines

 

12th April 2013

 

Summary Flowchart for the Adult Patient Pathway for Vitamin D Deficiency in Primary Care

 

Vitamin D Patient Information Leaflet


Newsletters and Minutes

 

12th April 2013

 

NICE Bites -latest Edition


Newsletters and Minutes

 

12th April 2013

 

MHRA Drug Safety Update - Latest Edition


Non Clinical Guidelines and Policies

 

12th April 2013

 

PbR Drugs Excluded Drugs Status for ELHE 2013/14 April 2013 update


Newsletters and Minutes

 

11th April 2013

 

Latest Edition of Interface


MHRA update

 

14th March 2013

 

Learning Package on Benzodiazepines launched by MHRA


Drug Alerts and Withdrawls

 

12th March 2013

 

Class 2 Drug Alert - Montelukast 5mg Chewable Tablets


Disease or Condition Specific

 

8th March 2013

 

ELHE Vitamin D Guidelines


Newsletters and Minutes

 

6th March 2013

 

Latest Edition of Interface


 

Joint Medicines Formulary

 

26th February 2013

 

HRT Formulary


Newsletters and Minutes

 

20th February 2013

 

MHRA Drug Safety Update January 2013


Newsletters and Minutes

 

20th February 2013

 

NICE Bites January 2013 - Psoriasis


Drug Alerts and Withdrawls

 

20th February 2013

 

MHRA Class 4 Drug Alert - Dexamfetamine Sulphate 5mg Tablets


Drug Alerts and Withdrawls

 

19th February 2013

 

Hong Kong DH issues warnings about Traditional Chinese medicines found to contain heavy metals


 Newsletters and Minutes

 

6th February 2013

 

Medicines Management Board Minutes (ELHE) December 2012


Drug Alerts and Withdrawls

 

1st February 2013

 

MHRA - Herbal Safety Warnings and Alerts -slimming products containing undeclared pharmaceuticals - warning from Danish Medicines Authority


 

Richard Lee, East Lancashire Health Economy New Drugs Pharmacist.

Email: Interface@bwd.nhs.uk

Powered by EasySite™ Content Management System